C-H.O hydrogen bonds in FK506-binding protein-ligand interactions

Journal of Molecular Recognition

Volumn 26, Issue 11, 2013, Pages 550-555

  Rajan, Sreekanth ^a   Baek, Kwanghee ^b   Yoon, Ho Sup ^a  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^b Kyung Hee University   (South Korea)

Author keywords

C H.O; FKBP; hydrogen bonds; protein ligand interaction

Indexed keywords

FK 506 BINDING PROTEIN; LIGAND; TACROLIMUS;

ANIMAL; ARTICLE; C-H...O; CHEMICAL STRUCTURE; CHEMISTRY; ENZYME ACTIVE SITE; FKBP; HUMAN; HYDROGEN BOND; HYDROGEN BONDS; METABOLISM; PROTEIN DATABASE; PROTEIN TERTIARY STRUCTURE; PROTEIN-LIGAND INTERACTION;

C-H...O; FKBP; HYDROGEN BONDS; PROTEIN-LIGAND INTERACTION;

ANIMALS; CATALYTIC DOMAIN; DATABASES, PROTEIN; HUMANS; HYDROGEN BONDING; LIGANDS; MODELS, MOLECULAR; PROTEIN STRUCTURE, TERTIARY; TACROLIMUS; TACROLIMUS BINDING PROTEINS;

EID: 84885656600     PISSN: 09523499     EISSN: 10991352     Source Type: Journal    
DOI: 10.1002/jmr.2299     Document Type: Article

References (58)

1. Ahearn IM, Tsai FD, Court H, Zhou M, Jennings BC, Ahmed M, Fehrenbacher N, Linder ME, Philips MR,. 2011. FKBP12 binds to acylated H-ras and promotes depalmitoylation. Mol. Cell 41 (2): 173-85.
2. Alag R, Qureshi IA, Bharatham N, Shin J, Lescar J, Yoon HS,. 2010. NMR and crystallographic structures of the FK506 binding domain of human malarial parasite Plasmodium vivax FKBP35. Protein Sci. 19 (8): 1577-86.
3. Alag R, Balakrishna AM, Rajan S, Qureshi IA, Shin J, Lescar J, Gruber G, Yoon HS,. 2013. Structural Insights into Substrate Binding by PvFKBP35, a Peptidylprolyl cis-trans Isomerase from the Human Malarial Parasite Plasmodium vivax. Eukaryot. Cell 12 (4): 627-34.
4. Aparna V, Rambabu G, Panigrahi SK, Sarma JA, Desiraju GR,. 2005. Virtual screening of 4-anilinoquinazoline analogues as EGFR kinase inhibitors: importance of hydrogen bonds in the evaluation of poses and scoring functions. J. Chem. Inf. Model. 45 (3): 725-38.
5. Barth S, Nesper J, Hasgall PA, Wirthner R, Nytko KJ, Edlich F, Katschinski DM, Stiehl DP, Wenger RH, Camenisch G,. 2007. The peptidyl prolyl cis/trans isomerase FKBP38 determines hypoxia-inducible transcription factor prolyl-4-hydroxylase PHD2 protein stability. Mol. Cell. Biol. 27 (10): 3758-68.
6. Blackburn EA, Walkinshaw MD,. 2011. Targeting FKBP isoforms with small-molecule ligands. Curr. Opin. Pharmacol. 11 (4): 365-71.
7. Bracher A, Kozany C, Thost AK, Hausch F,. 2011. Structural characterization of the PPIase domain of FKBP51, a cochaperone of human Hsp90. Acta Crystallogr. D Biol. Crystallogr. 67 (Pt 6): 549-59.
8. Burkhard P, Taylor P, Walkinshaw MD,. 2000. X-ray structures of small ligand-FKBP complexes provide an estimate for hydrophobic interaction energies. J. Mol. Biol. 295 (4): 953-62.
9. Cameron AM, Steiner JP, Sabatini DM, Kaplin AI, Walensky LD, Snyder SH,. 1995. Immunophilin FK506 binding protein associated with inositol 1,4,5-trisphosphate receptor modulates calcium flux. Proc Natl Acad Sci U S A 92 (5): 1784-8.
10. Chakrabarti P, Chakrabarti S,. 1998. C - H.O hydrogen bond involving proline residues in alpha-helices. J. Mol. Biol. 284 (4): 867-73.
11. Chattopadhaya S, Harikishore A, Yoon HS,. 2011. Role of FK506 binding proteins in neurodegenerative disorders. Curr. Med. Chem. 18 (35): 5380-97.
12. Choi BH, Feng L, Yoon HS,. 2010. FKBP38 protects Bcl-2 from caspase-dependent degradation. J. Biol. Chem. 285 (13): 9770-9.
13. Clackson T, Yang W, Rozamus LW, Hatada M, Amara JF, Rollins CT, Stevenson LF, Magari SR, Wood SA, Courage NL, Lu X, Cerasoli F, Jr, Gilman M, Holt DA,. 1998. Redesigning an FKBP-ligand interface to generate chemical dimerizers with novel specificity. Proc Natl Acad Sci U S A 95 (18): 10437- 42.
14. Crackower MA, Kolas NK, Noguchi J, Sarao R, Kikuchi K, Kaneko H, Kobayashi E, Kawai Y, Kozieradzki I, Landers R, Mo R, Hui CC, Nieves E, Cohen PE, Osborne LR, Wada T, Kunieda T, Moens PB, Penninger JM,. 2003. Essential role of Fkbp6 in male fertility and homologous chromosome pairing in meiosis. Science 300 (5623): 1291-5.
15. DeCenzo MT, Park ST, Jarrett BP, Aldape RA, Futer O, Murcko MA, Livingston DJ,. 1996. FK506-binding protein mutational analysis: defining the active-site residue contributions to catalysis and the stability of ligand complexes. Protein Eng. 9 (2): 173-80.
16. Derewenda ZS, Lee L, Derewenda U,. 1995. The occurrence of C-H.O hydrogen bonds in proteins. J. Mol. Biol. 252 (2): 248-62.
17. Desiraju GR,. 1991. The C-H-0 Hydrogen Bond in Crystals: What Is It? Acc. Chem. Res. 24 (10): 290-296.
18. Desiraju GR,. 2005. C-H.O and other weak hydrogen bonds. From crystal engineering to virtual screening. Chem. Commun. (Camb.) (24): 2995-3001.
19. Dubowchik GM, Vrudhula VM, Dasgupta B, Ditta J, Chen T, Sheriff S, Sipman K, Witmer M, Tredup J, Vyas DM, and others. 2001. 2-Aryl-2,2-difluoroacetamide FKBP12 ligands: synthesis and X-ray structural studies. Org. Lett. 3 (25): 3987-90.
20. Fabiola GF, Krishnaswamy S, Nagarajan V, Pattabhi V,. 1997. C-H.O hydrogen bonds in beta-sheets. Acta Crystallogr. D Biol. Crystallogr. 53 (Pt 3): 316-20.
21. Gaali S, Gopalakrishnan R, Wang Y, Kozany C, Hausch F,. 2011. The chemical biology of immunophilin ligands. Curr. Med. Chem. 18 (35): 5355-79.
22. Gopalakrishnan R, Kozany C, Gaali S, Kress C, Hoogeland B, Bracher A, Hausch F,. 2012a. Evaluation of synthetic FK506 analogues as ligands for the FK506-binding proteins 51 and 52. J. Med. Chem. 55 (9): 4114-22.
23. Gopalakrishnan R, Kozany C, Wang Y, Schneider S, Hoogeland B, Bracher A, Hausch F,. 2012b. Exploration of pipecolate sulfonamides as binders of the FK506-binding proteins 51 and 52. J. Med. Chem. 55 (9): 4123-31.
24. Gu Y, Kar T, Scheiner S,. 1999. Fundamental Properties of the CH · · · O Interaction: Is It a True Hydrogen Bond? J. Am. Chem. Soc. 121 (40): 9411-9422.
25. Holt DA, Luengo JI, Yamashita DS, Oh HJ, Konialian AL, Yen HK, Rozamus LW, Brandt M, Bossard MJ, Levy MA, Eggleston DS, Liang J, Schultz LW, Stout TJ, Clardy J,. 1993. Design, synthesis, and kinetic evaluation of high-affinity FKBP ligands and the X-ray crystal structures of their complexes with FKBP12. J. Am. Chem. Soc. 115 (22): 9925-9938.
26. Jayaraman T, Brillantes AM, Timerman AP, Fleischer S, Erdjument-Bromage H, Tempst P, Marks AR,. 1992. FK506 binding protein associated with the calcium release channel (ryanodine receptor). J. Biol. Chem. 267 (14): 9474-7.
27. Jinwal UK, Koren J, 3rd, Borysov SI, Schmid AB, Abisambra JF, Blair LJ, Johnson AG, Jones JR, Shults CL, O'Leary JC, 3rd, Jin Y, Buchner J, Cox MB, Dickey CA,. 2010. The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules. J. Neurosci. 30 (2): 591-9.
28. Kallen JA, Sedrani R, Cottens S,. 1996. X-ray Crystal Structure of 28-O-Methylrapamycin complexed with FKBP12: Is the Cyclohexyl Moiety Part of the Effector Domain of Rapamycin? J. Am. Chem. Soc. 118 (25): 5857-5861.
29. Kasahara K, Shirota M, Kinoshita K,. 2013. Comprehensive classification and diversity assessment of atomic contacts in protein-small ligand interactions. J. Chem. Inf. Model. 53 (1): 241-8.
30. Klaholz B, Moras D,. 2002. C-H.O hydrogen bonds in the nuclear receptor RARgamma - a potential tool for drug selectivity. Structure 10 (9): 1197-204.
31. Kuzuhara T, Horikoshi M,. 2004. A nuclear FK506-binding protein is a histone chaperone regulating rDNA silencing. Nat. Struct. Mol. Biol. 11 (3): 275-83.
32. Liang J, Choi J, Clardy J,. 1999. Refined structure of the FKBP12-rapamycin-FRB ternary complex at 2.2 A resolution. Acta Crystallogr. D Biol. Crystallogr. 55 (Pt 4): 736-44.
33. Lucke C, Weiwad M,. 2011. Insights into immunophilin structure and function. Curr. Med. Chem. 18 (35): 5333-54.
34. Marz AM, Fabian AK, Kozany C, Bracher A, Hausch F,. 2013. Large FK506-binding proteins shape the pharmacology of rapamycin. Mol. Cell. Biol. 33 (7): 1357-67.
35. Nelson CJ, Santos-Rosa H, Kouzarides T,. 2006. Proline isomerization of histone H3 regulates lysine methylation and gene expression. Cell 126 (5): 905-16.
36. Ochocka AM, Kampanis P, Nicol S, Allende-Vega N, Cox M, Marcar L, Milne D, Fuller-Pace F, Meek D,. 2009. FKBP25, a novel regulator of the p53 pathway, induces the degradation of MDM2 and activation of p53. FEBS Lett. 583 (4): 621-6.
37. Panigrahi SK,. 2008. Strong and weak hydrogen bonds in protein-ligand complexes of kinases: a comparative study. Amino Acids 34 (4): 617-33.
38. Panigrahi SK, Desiraju GR,. 2007. Strong and weak hydrogen bonds in drug-DNA complexes: a statistical analysis. J. Biosci. 32 (4): 677-91.
39. Peterson MR, Hall DR, Berriman M, Nunes JA, Leonard GA, Fairlamb AH, Hunter WN,. 2000. The three-dimensional structure of a Plasmodium falciparum cyclophilin in complex with the potent anti-malarial cyclosporin A. J. Mol. Biol. 298 (1): 123-33.
40. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE,. 2004. UCSF Chimera-a visualization system for exploratory research and analysis. J. Comput. Chem. 25 (13): 1605-12.
41. Pierce AC, Sandretto KL, Bemis GW,. 2002. Kinase inhibitors and the case for CH.O hydrogen bonds in protein-ligand binding. Proteins 49 (4): 567-76.
42. Rajan S, Saw KQ, Nguyen QT, Baek K, Yoon HS,. 2012. High-resolution crystal structure of FKBP12 from Aedes aegypti. Protein Sci. 21 (7): 1080-4.
43. Riggs DL, Roberts PJ, Chirillo SC, Cheung-Flynn J, Prapapanich V, Ratajczak T, Gaber R, Picard D, Smith DF,. 2003. The Hsp90-binding peptidylprolyl isomerase FKBP52 potentiates glucocorticoid signaling in vivo. EMBO J. 22 (5): 1158-67.
44. Sarkhel S, Desiraju GR,. 2004. N-H.O, O-H.O, and C-H.O hydrogen bonds in protein-ligand complexes: strong and weak interactions in molecular recognition. Proteins 54 (2): 247-59.
45. Saul FA, Arie JP, Vulliez-le Normand B, Kahn R, Betton JM, Bentley GA,. 2004. Structural and functional studies of FkpA from Escherichia coli, a cis/trans peptidyl-prolyl isomerase with chaperone activity. J. Mol. Biol. 335 (2): 595-608.
46. Scheiner S,. 2011. Weak H-bonds. Comparisons of CH.O to NH.O in proteins and PH.N to direct P.N interactions. Phys. Chem. Chem. Phys. 13 (31): 13860- 72.
47. Schultz LW, Clardy J,. 1998. Chemical inducers of dimerization: the atomic structure of FKBP12-FK1012A-FKBP12. Bioorg. Med. Chem. Lett. 8 (1): 1-6.
48. Shirane M, Nakayama KI,. 2003. Inherent calcineurin inhibitor FKBP38 targets Bcl-2 to mitochondria and inhibits apoptosis. Nat. Cell Biol. 5 (1): 28-37.
49. Tiwari A, Panigrahi SK,. 2007. HBAT: a complete package for analysing strong and weak hydrogen bonds in macromolecular crystal structures. In Silico Biol. 7 (6): 651-61.
50. Toth G, Bowers SG, Truong AP, Probst G,. 2007. The role and significance of unconventional hydrogen bonds in small molecule recognition by biological receptors of pharmaceutical relevance. Curr. Pharm. Des. 13 (34): 3476-93.
51. Van Duyne GD, Standaert RF, Karplus PA, Schreiber SL, Clardy J,. 1991. Atomic structure of FKBP-FK506, an immunophilin-immunosuppressant complex. Science 252 (5007): 839-42.
52. Van Duyne GD, Standaert RF, Karplus PA, Schreiber SL, Clardy J,. 1993. Atomic structures of the human immunophilin FKBP-12 complexes with FK506 and rapamycin. J. Mol. Biol. 229 (1): 105-24.
53. Wang XJ, Etzkorn FA,. 2006. Peptidyl-prolyl isomerase inhibitors. Biopolymers 84 (2): 125-46.
54. Wang T, Li BY, Danielson PD, Shah PC, Rockwell S, Lechleider RJ, Martin J, Manganaro T, Donahoe PK,. 1996. The immunophilin FKBP12 functions as a common inhibitor of the TGF beta family type I receptors. Cell 86 (3): 435-44.
55. Wang Y, Kirschner A, Fabian AK, Gopalakrishnan R, Kress C, Hoogeland B, Koch U, Kozany C, Bracher A, Hausch F,. 2013. Increasing the Efficiency of Ligands for FK506-Binding Protein 51 by Conformational Control. J. Med. Chem. 56 (10): 3922-35.
56. Wilson KP, Yamashita MM, Sintchak MD, Rotstein SH, Murcko MA, Boger J, Thomson JA, Fitzgibbon MJ, Black JR, Navia MA,. 1995. Comparative X-ray structures of the major binding protein for the immunosuppressant FK506 (tacrolimus) in unliganded form and in complex with FK506 and rapamycin. Acta Crystallogr. D Biol. Crystallogr. 51 (Pt 4): 511-21.
57. Yang WM, Inouye CJ, Seto E,. 1995. Cyclophilin A and FKBP12 interact with YY1 and alter its transcriptional activity. J. Biol. Chem. 270 (25): 15187- 93.
58. Zhao H, Huang D,. 2011. Hydrogen bonding penalty upon ligand binding. PLoS One 6 (6): e19923.